EverydayHealth

This week’s Research Roundup highlights the role of 3D-MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery.

Researchers at Mayo Clinic in Phoenix have found that knowing the test results from BioFire's rapid multiplex diagnostic panel for detecting blood stream infections does not actually alter certain aspects of clinician prescribing behavior, contradicting previous published reports.

Top highlights include: "big pharma" returning to raising U.S. prices in January after pause; crowdfunding drives funds and attention toward questionable medical treatments; Americans rate health care providers high on honesty, ethics, cancer treatment, and arthritis; and suicide rates on the rise in Minnesota.

Elizabeth Atneosen, a student in the Mayo Clinic Medical Laboratory Science program, discusses interesting applications she has learned thus far in the program.

Top highlights include: FDA panel backs prescribing opioid overdose reversal drug along with painkillers, Surgeon General warns youth vaping is now an "epidemic," international patients seeking cures in the states, Mayo Clinic President and CEO Dr. Noseworthy looks back at his legacy, and technology changes outlook for spinal cord injury recovery.

This week’s Research Roundup determines the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the clinical genome resource clinical validity framework.

Discussion is an effective pedagogical strategy to facilitate a learning experience and assess understanding. Carrie Bowler, Program Manager of Staff Development in the Department of Laboratory Medicine and Pathology, discusses the benefits of discussion as a strategy.

Top highlights include: NIH to spend up to $20 million on search for alternatives to fetal tissue for research, hospital beds get digital upgrade, cocaine deaths increase amid ongoing national opioid crisis, health insurers look to digital tools to improve customer experience, and teen vaping soared in 2018.

This week’s Research Roundup highlights phosphorylated RB promotes cancer immunity by inhibiting NF-κB activation and PD-L1 expression.

According to the Centers for Disease Control and Prevention (CDC), the Asian longhorned tick has spread across nine states since it first appeared in the U.S. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, discusses the risks.

Kylie Reising, a student in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course.

Nikola Baumann, Ph.D., Director of the Central Clinical Laboratory and Central Processing Laboratory at Mayo Clinic, was recently featured in CAP Today about biotin interference. According to findings of a Mayo Clinic study, biotin use is not rare, and don’t count on it being listed in the patient’s electronic medical record.

This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.